Kaposiform Hemangioendothelioma with Kasabach–Merritt Phenomenon in a Neonate: A Case Report
Sirolimus is a critical salvage therapy for refractory neonatal KHE-KMP, even in BCG-vaccinated infants. Timely initiation reverses life-threatening coagulopathy and achieves favorable outcomes, necessitating multidisciplinary monitoring to balance immunosuppression risks.
Authors
- Rongjie Wu (ORCID: https://orcid.org/0000-0002-4719-0919)
- Qilin Chen (ORCID: https://orcid.org/0000-0002-1872-1290)
- Wei Peng
- James Yun (ORCID: https://orcid.org/0000-0003-2533-4253)
- Shiyu Xiong
- Yuantian Zheng
Institutions
- Gannan Medical University (CN)
- First Affiliated Hospital of Gannan Medical University (CN)
Publication Details
- Journal
- European Journal of Pediatric Surgery Reports
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1055/a-2699-8104
- Primary Topic
- Vascular Malformations and Hemangiomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Health Commission of Jiangxi Province